Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1988 Nov;63(11):1368–1371. doi: 10.1136/adc.63.11.1368

Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism.

S S Abusrewil 1, L Tyfield 1, D C Savage 1
PMCID: PMC1779175  PMID: 3202645

Abstract

Serum thyroid stimulating hormone and thyroxine concentrations were monitored in 42 infants who had been treated for congenital hypothyroidism. Serum thyroid stimulating hormone concentrations were raised in 22 of the infants (52%) at 2 to 4 months, in 16 (38%) at 5 to 11 months, in 14 (33%) at 12 to 18 months, and in eight (19%) at 2 to 4 years. Serum thyroxine and the dose of L-thyroxine/kg/body weight were significantly lower in those infants with raised thyroid stimulating hormone concentrations. Thyroid stimulating hormone was appropriately suppressed when the dose of L-thyroxine was increased, and only one child had delayed maturation of the hypothalamic/pituitary/thyroid axis. We believe it is the infant's rapid gain in weight in the first two years of life that necessitates this decrease in the dose of L-thyroxine/kg body weight and recommend that the treatment of this age group is reviewed every two to three months.

Full text

PDF
1368

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbassi V., Aldige C. Evaluation of sodium L-thyroxine (T4) requirement in replacement therapy of hypothyroidism. J Pediatr. 1977 Feb;90(2):298–301. doi: 10.1016/s0022-3476(77)80656-2. [DOI] [PubMed] [Google Scholar]
  2. Desai M., Irani A. J., Colaco M. P., Raikar R. S., Sheth A. R., Patil K., Pandya C. S., Modi K. N. Therapy of childhood hypothyroidism: a reappraisal. Indian Pediatr. 1982 Nov;19(11):927–936. [PubMed] [Google Scholar]
  3. Dussault J. H., Coulombe P., Laberge C., Letarte J., Guyda H., Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975 May;86(5):670–674. doi: 10.1016/s0022-3476(75)80349-0. [DOI] [PubMed] [Google Scholar]
  4. Frost G. J., Parkin J. M. Management of patients with congenital hypothyroidism. Br Med J (Clin Res Ed) 1985 May 18;290(6480):1485–1489. doi: 10.1136/bmj.290.6480.1485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Glorieux J., Dussault J. H., Letarte J., Guyda H., Morissette J. Preliminary results on the mental development of hypothyroid infants detected by the Quebec Screening Program. J Pediatr. 1983 Jan;102(1):19–22. doi: 10.1016/s0022-3476(83)80279-0. [DOI] [PubMed] [Google Scholar]
  6. Glorieux J., Dussault J. H., Morissette J., Desjardins M., Letarte J., Guyda H. Follow-up at ages 5 and 7 years on mental development in children with hypothyroidism detected by Quebec Screening Program. J Pediatr. 1985 Dec;107(6):913–915. doi: 10.1016/s0022-3476(85)80187-6. [DOI] [PubMed] [Google Scholar]
  7. Hulse J. A., Grant D. B., Jackson D., Clayton B. E. Growth, development, and reassessment of hypothyroid infants diagnosed by screening. Br Med J (Clin Res Ed) 1982 May 15;284(6327):1435–1437. doi: 10.1136/bmj.284.6327.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Klein A. H., Agustin A. V., Foley T. P., Jr Successful laboratory screening for congenital hypothyroidism. Lancet. 1974 Jul 13;2(7872):77–79. doi: 10.1016/s0140-6736(74)91637-7. [DOI] [PubMed] [Google Scholar]
  9. Klein A. H., Meltzer S., Kenny F. M. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr. 1972 Nov;81(5):912–915. doi: 10.1016/s0022-3476(72)80542-0. [DOI] [PubMed] [Google Scholar]
  10. Macfaul R., Dorner S., Brett E. M., Grant D. B. Neurological abnormalities in patients treated for hypothyroidism from early life. Arch Dis Child. 1978 Aug;53(8):611–619. doi: 10.1136/adc.53.8.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murphy G., Hulse J. A., Jackson D., Tyrer P., Glossop J., Smith I., Grant D. Early treated hypothyroidism: development at 3 years. Arch Dis Child. 1986 Aug;61(8):761–765. doi: 10.1136/adc.61.8.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rezvani I., DiGeorge A. M. Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children. J Pediatr. 1977 Feb;90(2):291–297. doi: 10.1016/s0022-3476(77)80655-0. [DOI] [PubMed] [Google Scholar]
  13. Rovet J. F., Westbrook D. L., Ehrlich R. M. Neonatal thyroid deficiency: early temperamental and cognitive characteristics. J Am Acad Child Psychiatry. 1984 Jan;23(1):10–22. doi: 10.1097/00004583-198401000-00003. [DOI] [PubMed] [Google Scholar]
  14. Sato T., Suzuki Y., Taketani T., Ishiguro K., Nakajima H. Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism. J Clin Endocrinol Metab. 1977 Mar;44(3):553–559. doi: 10.1210/jcem-44-3-553. [DOI] [PubMed] [Google Scholar]
  15. Schultz R. M., Glassman M. S., MacGillivray M. H. Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child. 1980 Jan;134(1):19–20. doi: 10.1001/archpedi.1980.02130130011004. [DOI] [PubMed] [Google Scholar]
  16. Soyka L. F., Redmond G. P. Problems in the treatment of neonates with genetic diseases of the thyroid. Prog Clin Biol Res. 1979;34:331–342. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES